Johannes Siebermair
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Johannes Siebermair has a total of 56 co-authors. Here are the top co-authors by number of shared publications:
- Christoph Rischpler
Klinik für Nuklearmedizin, Katharinenhospital, Klinikum Stuttgart, Stuttgart, Deutschland
5 shared publications - Reza Wakili
Department of Cardiology, Goethe University Frankfurt, University Heart Center , Theodor-Stern-Kai 7, Frankfurt 60596
4 shared publications Tienush Rassaf
Department of Cardiology and Vascular Medicine, West German Heart and Vascular Center Essen, University Duisburg-Essen , 45147, Essen, Germany
4 shared publications- Tienush Rassaf
Department of Cardiology and Vascular Medicine, West-German Heart and Vascular Center Essen, University of Duisburg-Essen, Hufelandstr. 55, 45147 Essen, Germany
4 shared publications Jana Kupusovic
Department of Cardiology and Vascular Medicine, West German Heart and Vascular Center Essen, University Duisburg-Essen , 45147, Essen, Germany
3 shared publications- Jana Kupusovic
Department of Cardiology and Vascular Medicine, University Heart and Vascular Center Frankfurt, Goethe University Frankfurt , Theodor-Stern Kai 7, Frankfurt am Main 60590
3 shared publications
Latest Publications
- Open Access
- 22 January 2024
- Published by Elsevier in IJC Heart & Vasculature
- Vol. 50, 101340
Delayed 68Ga-FAPI-46 PET/MR imaging confirms ongoing fibroblast activation in patients after acute myocardial infarction
- 22 January 2024
- Published by Elsevier in IJC Heart & Vasculature
- Vol. 50, 101340
Open AccessDelayed 68Ga-FAPI-46 PET/MR imaging confirms ongoing fibroblast activation in patients after acute myocardial infarction
- Open Access
- 26 March 2023
- Published by Elsevier in Journal of Nuclear Cardiology
- Vol. 30 (5) , 2018-2028
Visualization of fibroblast activation using 68Ga-FAPI PET/CT after pulmonary vein isolation with pulsed field compared with cryoballoon ablation
- 26 March 2023
- Published by Elsevier in Journal of Nuclear Cardiology
- Vol. 30 (5) , 2018-2028
Open AccessVisualization of fibroblast activation using 68Ga-FAPI PET/CT after pulmonary vein isolation with pulsed field compared with cryoballoon ablation
- Open Access
- 13 March 2023
- Published by Oxford University Press (OUP) in International Health
- Vol. 16 (1) , 120-122
Post-traumatic stress disorder among COVID-19-affected high-risk cardiac patients
Background: During the first coronavirus disease 2019 (COVID-19) wave there was a high prevalence of mental health impairments and post-traumatic stress disorder (PTSD), particularly in patients with comorbid cardiac diseases. Methods: During waves 2–5, all hospitalized patients with cardiac problems and suspected COVID-19 were eligible to participate in this study. Results: The prevalence of PTSD was 31.4% (n=48) in 153 participants. No age- and gender-related differences for PTSD were found. Conclusions: The prevalence is lower than during the first wave but higher than in patients reported in other studies who were isolated at home. Routine mental health assessments are strongly recommended for patients at risk.
- 13 March 2023
- Published by Oxford University Press (OUP) in International Health
- Vol. 16 (1) , 120-122
Open AccessPost-traumatic stress disorder among COVID-19-affected high-risk cardiac patients
Background: During the first coronavirus disease 2019 (COVID-19) wave there was a high prevalence of mental health impairments and post-traumatic stress disorder (PTSD), particularly in patients with comorbid cardiac diseases. Methods: During waves 2–5, all hospitalized patients with cardiac problems and suspected COVID-19 were eligible to participate in this study. Results: The prevalence of PTSD was 31.4% (n=48) in 153 participants. No age- and gender-related differences for PTSD were found. Conclusions: The prevalence is lower than during the first wave but higher than in patients reported in other studies who were isolated at home. Routine mental health assessments are strongly recommended for patients at risk.
- Open Access
- 9 January 2022
- Published by Oxford University Press (OUP) in European Heart Journal - Case Reports
- Vol. 6 (1) , ytac005
Cardiac fibroblast activation detected by 68Gallium-FAPI-46 positron emission tomography–magnetic resonance imaging as a sign of chronic activity in cardiac sarcoidosis
One year after being diagnosed with Stage I pulmonary sarcoidosis by lymph node extraction, a 58-years old female patient without a history of heart disease presented with shortness of breath, fatigue, N-terminal prohormone of brain natriuretic peptide (NT-proBNP) levels of 11 865 pg/mL (Panels A1–3, light green arrows) and late gadolinium enhancement (LGE; Panel A4, red arrow) in the septal and posterior wall of the left ventricle, confirming the diagnosis of cardiac sarcoidosis (CS). Heart failure medication with spironolactone, sacubitril/valsartan, bisoprolol, and high doses of corticosteroids (methylprednisolone 80 mg/day) was initiated. In addition, the patient was provided with an external defibrillation vest for markedly reduced systolic function and active inflammation in cardiac sarcoidosis.
- 9 January 2022
- Published by Oxford University Press (OUP) in European Heart Journal - Case Reports
- Vol. 6 (1) , ytac005
Open AccessCardiac fibroblast activation detected by 68Gallium-FAPI-46 positron emission tomography–magnetic resonance imaging as a sign of chronic activity in cardiac sarcoidosis
One year after being diagnosed with Stage I pulmonary sarcoidosis by lymph node extraction, a 58-years old female patient without a history of heart disease presented with shortness of breath, fatigue, N-terminal prohormone of brain natriuretic peptide (NT-proBNP) levels of 11 865 pg/mL (Panels A1–3, light green arrows) and late gadolinium enhancement (LGE; Panel A4, red arrow) in the septal and posterior wall of the left ventricle, confirming the diagnosis of cardiac sarcoidosis (CS). Heart failure medication with spironolactone, sacubitril/valsartan, bisoprolol, and high doses of corticosteroids (methylprednisolone 80 mg/day) was initiated. In addition, the patient was provided with an external defibrillation vest for markedly reduced systolic function and active inflammation in cardiac sarcoidosis.
- Open Access
- 15 November 2021
- Published by Springer Nature in European Journal of Nuclear Medicine and Molecular Imaging
- Vol. 49 (5) , 1553-1559
Visualization of thermal damage using 68 Ga-FAPI-PET/CT after pulmonary vein isolation
Purpose: 68 Ga-fibroblast-activation protein inhibitor (FAPI) positron emission tomography (PET) is a novel technique targeting FAP-alpha. This protein is expressed by activated fibroblasts which are the main contributors to tissue remodeling. The aim of this proof-of-concept study was to assess 68 Ga-FAPI uptake in the pulmonary vein (PV) region of the left atrium after pulmonary vein isolation (PVI) with cryoballoon ablation (CBA) and radiofrequency (RFA) as a surrogate for thermal damage. Methods: Twelve PVI patients (5 RFA, 7 CBA) underwent 68 Ga-FAPI-PET 20.5 ± 12.8 days after PVI. Five patients without atrial fibrillation or previous ablation served as controls. Standardized uptake values of localized tracer uptake were calculated. Results: Focal FAPI uptake around the PVs was observed in 10/12 (83.3%) PVI patients, no uptake was observed in 2 PVI patients and all controls. Patients after PVI had higher FAPI uptake in PVs compared to controls (SUVmax: 4.3 ± 2.2 vs. 1.6 ± 0.2, p < 0.01; SUVpeak: 2.9 ± 1.4 vs. 1.3 ± 0.2, p < 0.01). All CBA patients had an intense uptake, while in the RFA, group 2 (40%), 1 (20%), and 2 (40%) patients had an intense, moderate, and no uptake, respectively. We observed higher uptake values (SUVpeak) in CBA compared to RFA patients (4.4 ± 1.5 vs. 2.5 ± 0.8, p = 0.02). Conclusion: We demonstrate in-vivo visualization of 68 Ga-FAPI uptake as a surrogate for fibroblast activation after PVI. CBA seems to cause more pronounced fibroblast activation following tissue injury than RFA. Future studies are warranted to assess if this modality can contribute to a better understanding of the mechanisms of AF recurrence after PVI by lesion creation and gap assessment.
- 15 November 2021
- Published by Springer Nature in European Journal of Nuclear Medicine and Molecular Imaging
- Vol. 49 (5) , 1553-1559
Open AccessVisualization of thermal damage using 68 Ga-FAPI-PET/CT after pulmonary vein isolation
Purpose: 68 Ga-fibroblast-activation protein inhibitor (FAPI) positron emission tomography (PET) is a novel technique targeting FAP-alpha. This protein is expressed by activated fibroblasts which are the main contributors to tissue remodeling. The aim of this proof-of-concept study was to assess 68 Ga-FAPI uptake in the pulmonary vein (PV) region of the left atrium after pulmonary vein isolation (PVI) with cryoballoon ablation (CBA) and radiofrequency (RFA) as a surrogate for thermal damage. Methods: Twelve PVI patients (5 RFA, 7 CBA) underwent 68 Ga-FAPI-PET 20.5 ± 12.8 days after PVI. Five patients without atrial fibrillation or previous ablation served as controls. Standardized uptake values of localized tracer uptake were calculated. Results: Focal FAPI uptake around the PVs was observed in 10/12 (83.3%) PVI patients, no uptake was observed in 2 PVI patients and all controls. Patients after PVI had higher FAPI uptake in PVs compared to controls (SUVmax: 4.3 ± 2.2 vs. 1.6 ± 0.2, p < 0.01; SUVpeak: 2.9 ± 1.4 vs. 1.3 ± 0.2, p < 0.01). All CBA patients had an intense uptake, while in the RFA, group 2 (40%), 1 (20%), and 2 (40%) patients had an intense, moderate, and no uptake, respectively. We observed higher uptake values (SUVpeak) in CBA compared to RFA patients (4.4 ± 1.5 vs. 2.5 ± 0.8, p = 0.02). Conclusion: We demonstrate in-vivo visualization of 68 Ga-FAPI uptake as a surrogate for fibroblast activation after PVI. CBA seems to cause more pronounced fibroblast activation following tissue injury than RFA. Future studies are warranted to assess if this modality can contribute to a better understanding of the mechanisms of AF recurrence after PVI by lesion creation and gap assessment.
- 18 June 2021
- Published by Oxford University Press (OUP) in British Journal of Radiology
- Vol. 94 (1123) , 20210048
Saturation recovery-prepared magnetic resonance angiography for assessment of left atrial and esophageal anatomy
Objectives: Magnetic resonance angiography (MRA) has been established as an important imaging method in cardiac ablation procedures. In pulmonary vein (PV) isolation procedures, MRA has the potential to minimize the risk of severe complications, such as atrio-esophageal fistula, by providing detailed information on esophageal position relatively to cardiac structures. However, traditional non-gated, first-pass (FP) MRA approaches have several limitations, such as long breath-holds, non-uniform signal intensity throughout the left atrium (LA), and poor esophageal visualization. The aim of this observational study was to validate a respiratory-navigated, ECG-gated (EC), saturation recovery-prepared MRA technique for simultaneous imaging of LA, LA appendage, PVs, esophagus, and adjacent anatomical structures. Methods: Before PVI, 106 consecutive patients with a history of AF underwent either conventional FP-MRA (n = 53 patients) or our new EC-MRA (n = 53 patients). Five quality scores (QS) of LA and esophagus visibility were assessed by two experienced readers. The non-parametric Mann–Whitney U-test was used to compare QS between FP-MRA and EC-MRA groups, and linear regression was applied to assess clinical contributors to image quality. Results: EC-MRA demonstrated significantly better image quality than FP-MRA in every quality category. Esophageal visibility using the new MRA technique was markedly better than with the conventional FP-MRA technique (median 3.5 [IQR 1] vs median 1.0, p < 0.001). In contrast to FP-MRA, overall image quality of EC-MRA was not influenced by heart rate. Conclusion: Our ECG-gated, respiratory-navigated, saturation recovery-prepared MRA technique provides significantly better image quality and esophageal visibility than the established non-gated, breath-holding FP-MRA. Image quality of EC-MRA technique has the additional advantage of being unaffected by heart rate. Advances in knowledge: Detailed information of cardiac anatomy has the potential to minimize the risk of severe complications and improve success rates in invasive electrophysiological studies. Our novel ECG-gated, respiratory-navigated, saturation recovery-prepared MRA technique provides significantly better image quality of LA and esophageal structures than the traditional first-pass algorithm. This new MRA technique is robust to arrhythmia (tachycardic, irregular heart rates) frequently observed in AF patients.
- 18 June 2021
- Published by Oxford University Press (OUP) in British Journal of Radiology
- Vol. 94 (1123) , 20210048
Saturation recovery-prepared magnetic resonance angiography for assessment of left atrial and esophageal anatomy
Objectives: Magnetic resonance angiography (MRA) has been established as an important imaging method in cardiac ablation procedures. In pulmonary vein (PV) isolation procedures, MRA has the potential to minimize the risk of severe complications, such as atrio-esophageal fistula, by providing detailed information on esophageal position relatively to cardiac structures. However, traditional non-gated, first-pass (FP) MRA approaches have several limitations, such as long breath-holds, non-uniform signal intensity throughout the left atrium (LA), and poor esophageal visualization. The aim of this observational study was to validate a respiratory-navigated, ECG-gated (EC), saturation recovery-prepared MRA technique for simultaneous imaging of LA, LA appendage, PVs, esophagus, and adjacent anatomical structures. Methods: Before PVI, 106 consecutive patients with a history of AF underwent either conventional FP-MRA (n = 53 patients) or our new EC-MRA (n = 53 patients). Five quality scores (QS) of LA and esophagus visibility were assessed by two experienced readers. The non-parametric Mann–Whitney U-test was used to compare QS between FP-MRA and EC-MRA groups, and linear regression was applied to assess clinical contributors to image quality. Results: EC-MRA demonstrated significantly better image quality than FP-MRA in every quality category. Esophageal visibility using the new MRA technique was markedly better than with the conventional FP-MRA technique (median 3.5 [IQR 1] vs median 1.0, p < 0.001). In contrast to FP-MRA, overall image quality of EC-MRA was not influenced by heart rate. Conclusion: Our ECG-gated, respiratory-navigated, saturation recovery-prepared MRA technique provides significantly better image quality and esophageal visibility than the established non-gated, breath-holding FP-MRA. Image quality of EC-MRA technique has the additional advantage of being unaffected by heart rate. Advances in knowledge: Detailed information of cardiac anatomy has the potential to minimize the risk of severe complications and improve success rates in invasive electrophysiological studies. Our novel ECG-gated, respiratory-navigated, saturation recovery-prepared MRA technique provides significantly better image quality of LA and esophageal structures than the traditional first-pass algorithm. This new MRA technique is robust to arrhythmia (tachycardic, irregular heart rates) frequently observed in AF patients.
- Open Access
- 21 April 2020
- Published by Wiley in Journal of Cardiovascular Electrophysiology
- Vol. 31 (7) , 1631-1639
Impact of previous left atrial ablation procedures on the mechanism of left atrial flutter: A single‐centre experience
Introduction: Left atrial flutter predominantly occurs after surgical or ablation procedures but this entity has also been recently reported in individuals without previous interventions. The use of high‐density electroanatomical mapping‐systems (HDM) has improved the understanding of underlying mechanisms beyond entrainment maneuvers and substrate analyses. We aimed to evaluate the mechanism of left atrial (LA) flutters in preablated vs ablation‐naïve individuals and sought to assess the efficacy of empiric ablations sets in these groups.Methods and results: We included 55 patients admitted for ablation of LA flutter between July 2017 and August 2019. On the basis of HDM analyses the arrhythmia mechanism was determined with consecutive ablation targeting the suspected critical isthmus.Mean age was 69.8 ± 10.7 years, with 26 of 55 (47.3%) male patients. Thirty‐nine (71%) patients had previously undergone LA ablation. Arrhythmia mechanisms differed between preablated and ablation‐naïve patients as anatomical structure‐related LA flutters (perimitral, roof‐dependent, within‐pulmonary veins) were more frequent in the preablated cohort compared to ablation‐naïve individuals (74.4% vs 43.8%; P = .03). In ablation‐naïve patients, most flutters (9 of 16, 56.3%) were related to low‐voltage areas at the anterior/posterior wall. Acute termination rates were high (>90%) in both groups. Empirical mitral isthmus or roof lines showed a potential higher success rate in preablated patients.Conclusion: We identified different mechanisms of LA flutters in preablated vs ablation‐naïve patients. In ablation‐naïve patients, most tachycardias involved low‐voltage areas rather than anatomical structures. Using HDM, acute success rates were high. Hypothetical linear ablations were less successful in ablation‐naïve individuals, further highlighting the need to identify the specific individual tachycardia mechanism in these patients.
- 21 April 2020
- Published by Wiley in Journal of Cardiovascular Electrophysiology
- Vol. 31 (7) , 1631-1639
Open AccessImpact of previous left atrial ablation procedures on the mechanism of left atrial flutter: A single‐centre experience
Introduction: Left atrial flutter predominantly occurs after surgical or ablation procedures but this entity has also been recently reported in individuals without previous interventions. The use of high‐density electroanatomical mapping‐systems (HDM) has improved the understanding of underlying mechanisms beyond entrainment maneuvers and substrate analyses. We aimed to evaluate the mechanism of left atrial (LA) flutters in preablated vs ablation‐naïve individuals and sought to assess the efficacy of empiric ablations sets in these groups.Methods and results: We included 55 patients admitted for ablation of LA flutter between July 2017 and August 2019. On the basis of HDM analyses the arrhythmia mechanism was determined with consecutive ablation targeting the suspected critical isthmus.Mean age was 69.8 ± 10.7 years, with 26 of 55 (47.3%) male patients. Thirty‐nine (71%) patients had previously undergone LA ablation. Arrhythmia mechanisms differed between preablated and ablation‐naïve patients as anatomical structure‐related LA flutters (perimitral, roof‐dependent, within‐pulmonary veins) were more frequent in the preablated cohort compared to ablation‐naïve individuals (74.4% vs 43.8%; P = .03). In ablation‐naïve patients, most flutters (9 of 16, 56.3%) were related to low‐voltage areas at the anterior/posterior wall. Acute termination rates were high (>90%) in both groups. Empirical mitral isthmus or roof lines showed a potential higher success rate in preablated patients.Conclusion: We identified different mechanisms of LA flutters in preablated vs ablation‐naïve patients. In ablation‐naïve patients, most tachycardias involved low‐voltage areas rather than anatomical structures. Using HDM, acute success rates were high. Hypothetical linear ablations were less successful in ablation‐naïve individuals, further highlighting the need to identify the specific individual tachycardia mechanism in these patients.
- 19 October 2019
- Published by Oxford University Press (OUP) in European Heart Journal
- Vol. 41 (9) , 1060
Cardiac fibroblast activation detected by positron emission tomography/computed tomography as a possible sign of cardiotoxicity
- 19 October 2019
- Published by Oxford University Press (OUP) in European Heart Journal
- Vol. 41 (9) , 1060
Cardiac fibroblast activation detected by positron emission tomography/computed tomography as a possible sign of cardiotoxicity
- 19 January 2019
- Published by Wiley in Journal of Cardiovascular Electrophysiology
- Vol. 30 (4) , 550-556
Atrial fibrosis in non–atrial fibrillation individuals and prediction of atrial fibrillation by use of late gadolinium enhancement magnetic resonance imaging
Introduction: Besides the traditional concept of atrial fibrillation (AF) perpetuating atrial structural remodeling, there is increasing evidence that atrial fibrosis might precede AF, highlighting the need for better characterization of the fibrotic substrate. We aimed to assess atrial fibrosis by use of late gadolinium enhancement magnetic resonance imaging (LGE‐MRI) in non‐AF individuals and to identify predisposing risk factors. A second aim was to establish a risk score for the prevalence of AF using atrial fibrosis in addition to established clinical variables.Methods and Results: Non‐AF individuals without structural heart disease (n = 91) and matched AF controls (n = 91) underwent MRI for assessment of LGE. According to the established UTAH classification, atrial LGE ≥20% was considered extensive.Mean left atrial (LA) fibrosis in non‐AF and AF individuals were 8.8 ± 6.5% and 12.5 ± 5.8%, respectively. Body mass index (BMI) >30 kg/m 2 and LA volume were predictors of atrial fibrosis. Diastolic function was not significantly different with respect to atrial fibrosis. A novel scoring system for the prevalence of AF (2 points for arterial hypertension and/or left ventricular ejection fraction 6%) was derived demonstrating that patients in the intermediate/high‐risk group had a significantly increased risk of AF.Conclusion: This study reports unexpectedly high atrial fibrosis in non‐AF patients without apparent heart disease, highlighting the concept that structural fibrotic alterations may precede AF onset in a significant proportion of individuals. BMI as a predictor of atrial fibrosis suggests that lifestyle and drug intervention, that is, weight reduction, could positively influence fibrosis development. The derived risk score for AF prevalence provides the basis for prospective studies on AF incidence.
- 19 January 2019
- Published by Wiley in Journal of Cardiovascular Electrophysiology
- Vol. 30 (4) , 550-556
Atrial fibrosis in non–atrial fibrillation individuals and prediction of atrial fibrillation by use of late gadolinium enhancement magnetic resonance imaging
Introduction: Besides the traditional concept of atrial fibrillation (AF) perpetuating atrial structural remodeling, there is increasing evidence that atrial fibrosis might precede AF, highlighting the need for better characterization of the fibrotic substrate. We aimed to assess atrial fibrosis by use of late gadolinium enhancement magnetic resonance imaging (LGE‐MRI) in non‐AF individuals and to identify predisposing risk factors. A second aim was to establish a risk score for the prevalence of AF using atrial fibrosis in addition to established clinical variables.Methods and Results: Non‐AF individuals without structural heart disease (n = 91) and matched AF controls (n = 91) underwent MRI for assessment of LGE. According to the established UTAH classification, atrial LGE ≥20% was considered extensive.Mean left atrial (LA) fibrosis in non‐AF and AF individuals were 8.8 ± 6.5% and 12.5 ± 5.8%, respectively. Body mass index (BMI) >30 kg/m 2 and LA volume were predictors of atrial fibrosis. Diastolic function was not significantly different with respect to atrial fibrosis. A novel scoring system for the prevalence of AF (2 points for arterial hypertension and/or left ventricular ejection fraction 6%) was derived demonstrating that patients in the intermediate/high‐risk group had a significantly increased risk of AF.Conclusion: This study reports unexpectedly high atrial fibrosis in non‐AF patients without apparent heart disease, highlighting the concept that structural fibrotic alterations may precede AF onset in a significant proportion of individuals. BMI as a predictor of atrial fibrosis suggests that lifestyle and drug intervention, that is, weight reduction, could positively influence fibrosis development. The derived risk score for AF prevalence provides the basis for prospective studies on AF incidence.